Surrey Heartlands

Joint Formulary & PAD

Azathioprine - Transplant immunosuppression

You are here : Home > Formulary Search > Azathioprine - Transplant immunosuppression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important

For EXISTING patients only - GPs may continue prescribing for existing post-transplant patients only. NHS England are looking to repatriate these patients in the future. GPs must not accept requests to prescribe for new patients.

 

Status 2

Red
Formulations :
  • Suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
For NEW patients - funded by NHS England. GPs should not accept any new request to start prescribing post-transplant

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Azathioprine
Indication :
Transplant immunosuppression
Group Name :
Keywords :
Brand Names Include :
Jayempi
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Azathioprine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Transplant immunosuppression.

Committee Recommendations (1)

06 Mar 24 - Not Set

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.